General Information of the Compound
| Compound ID |
CP0864613
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(5R*)-N5-[(2-Methoxypyridin-4-yl)methyl]-(6R*)-N6-(4-pyrrolidino-butyl)-(4S*,7R*)-[4,7-ethenylene-spiro[2.4]heptane]-5,6-dicarboxamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C26H36N4O3
|
||||||||||||||||||
| Molecular Weight |
452.599
|
||||||||||||||||||
| Canonical SMILES |
COc1cc(CNC(=O)[C@H]2[C@H](C(=O)NCCCCN3CCCC3)[C@H]3C=C[C@@H]2C32CC2)ccn1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C26H36N4O3/c1-33-21-16-18(8-12-27-21)17-29-25(32)23-20-7-6-19(26(20)9-10-26)22(23)24(31)28-11-2-3-13-30-14-4-5-15-30/h6-8,12,16,19-20,22-23H,2-5,9-11,13-15,17H2,1H3,(H,28,31)(H,29,32)/t19-,20+,22-,23-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
GVAKNVWYDBGEBB-IRMYBRCSSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00605, FML2_HUMAN
Protein ID: PT02590, N-formyl peptide receptor 2